BeOne Medicines (ONC) Retained Earnings (2016 - 2025)
Historic Retained Earnings for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to -$8.4 billion.
- BeOne Medicines' Retained Earnings rose 81.08% to -$8.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 billion, marking a year-over-year increase of 81.08%. This contributed to the annual value of -$8.6 billion for FY2024, which is 809.82% down from last year.
- As of Q3 2025, BeOne Medicines' Retained Earnings stood at -$8.4 billion, which was up 81.08% from -$8.5 billion recorded in Q2 2025.
- In the past 5 years, BeOne Medicines' Retained Earnings registered a high of -$3.5 billion during Q1 2021, and its lowest value of -$8.6 billion during Q4 2024.
- In the last 5 years, BeOne Medicines' Retained Earnings had a median value of -$7.6 billion in 2023 and averaged -$6.9 billion.
- As far as peak fluctuations go, BeOne Medicines' Retained Earnings plummeted by 5490.49% in 2022, and later surged by 81.08% in 2025.
- BeOne Medicines' Retained Earnings (Quarter) stood at -$5.1 billion in 2021, then tumbled by 39.47% to -$7.1 billion in 2022, then decreased by 12.45% to -$8.0 billion in 2023, then decreased by 8.1% to -$8.6 billion in 2024, then rose by 2.56% to -$8.4 billion in 2025.
- Its last three reported values are -$8.4 billion in Q3 2025, -$8.5 billion for Q2 2025, and -$8.6 billion during Q1 2025.